BioGenCell–SEVERAL: investment, 202205 seed financing round $16m led by private investor Marius Nacht

	Period	2022-05-09
	Money taker	BioGenCell Ltd.
	Money source	SEVERAL
	Product	TRACT technology (Tissue Regenerative Activated Cell Therapy)
	Product 2	venture capital
	Person	Nacht, Marius (aMoon 201701 Co-Founder plus Co-Founder + Chairman of Check Point Software Technologies)
	Person 2	Yaron, Uri (Head of Marius Nacht’s biotech + health investment arm)

BioGenCell Ltd.. (5/9/22). "Press Release: BioGenCell Raises $16 Million Seed Round Led by Marius Nacht for Microvascular Diseases Treatement".

The Israeli startup uses stem cells from the patient’s own blood to treat microvascular diseases and is aiming to develop products that may be usable to restore tissues damaged by diabetes, kidney failure, pulmonary hypertension, heart failure, stroke, blindness, and more

BioGenCell has completed a $16 million Seed round led by private investor Marius Nacht. BioGenCell, which was founded by Dr. Yael Porat and Prof. Michael Belkin, develops technology for using stem cells from the patient’s own blood to treat microvascular diseases.

Read more obout it in the following links:

"BioGenCell raises $16m. for chronic disease treatment."
Read from Jerusalem Post here
https://www.jpost.com/business-and-innovation/tech-and-start-ups/article-706214

"BioGenCell raises $16 million Seed round led by Marius Nacht for microvascular diseases treatment."
Read from Calcalist here
https://www.calcalistech.com/ctechnews/article/sywu8eil5

"BioGenCell completes $16 million seed round, gears for Phase 2 trial."
Read from Israel Hayom here
https://www.israelhayom.com/2022/05/10/biogencell-completes-16-million-seed-round-gears-for-phase-2-trial/